Europe drug delivery devices market is expected to grow at a substantial CAGR during the forecast period. The Europe drug delivery devices market is driven by improving patient compliance and beneficial reimbursement policies. Moreover, surging research & development activities is anticipated to positively impact the growth of market during the forecast period. Furthermore, rising FDA approvals is further expected to bolster the growth of market over the next few years.

With COVID-19 infections still on the rise, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected has also widened. In addition to this, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others), which is anticipated to fuel the market growth over the coming years.

The Europe drug delivery devices market is segmented based on route of administration, device, patient care setting, application, company, and country. Based on device, the market can be categorized into syringes, inhalers, patch pumps, and others. Out of which, the syringes segment dominated the market until 2019 and is expected to maintain its dominance during the forecast period as well as they are found to be of convenient usage and low healthcare cost. In addition to this, syringes provide efficient and reliable method for drug administration, which is further anticipated to fuel the segmental growth in the years to come.

Major players operating in the Europe drug delivery devices market include F. Hoffmann-La Roche Ltd, Antares Pharma, Novartis AG, 3M Company, Sulzer Ltd, Gerresheimer AG, Sanofi S.A., Johnson & Johnson Services, Inc., Bayer AG, GlaxoSmithKline plc, Novosanis, MEDMIX SYSTEMS AG, Merck & Co., Inc., Pfizer Inc., Insulet Corporation, OraSure Technologies, Inc., West Pharmaceutical Services, Inc., SMC Ltd., ViVO Smart Medical Devices Ltd., Cipla Inc. and others. The market players are adopting some competitive strategies such as technological developments, mergers & acquisitions, partnership, collaborations, agreements in order to expand their geographic reach and to increase their customer bases.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of Europe drug delivery devices market from 2015 to 2018.
  • To estimate and forecast the market size of Europe drug delivery devices market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast Europe drug delivery devices market based on route of administration, device, patient care setting, application, company and country wise distribution.
  • To identify dominant country or segment in the Europe drug delivery devices market.
  • To identify drivers and challenges for Europe drug delivery devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Europe drug delivery devices market.
  • To conduct pricing analysis for Europe drug delivery devices market.
  • To identify and analyze the profile of leading players operating in Europe drug delivery devices market.
  • To identify key sustainable strategies adopted by market players in Europe drug delivery devices market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the region. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers and presence of all major players across the region.

TechSci Research calculated the market size of Europe drug delivery devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Drug delivery devices manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to drug delivery devices
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Europe drug delivery devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Europe Drug Delivery Devices Market, By Route of Administration:
    • Oral Drug Delivery
    • Injectable Drug Deliver
    • Topical Drug Delivery
    • Ocular Drug Delivery
    • Pulmonary Drug Delivery
    • Nasal Drug Delivery
    • Transmucosal Drug Delivery
    • Implantable Drug Delivery
  • Europe Drug Delivery Devices Market, By Device:
    • Syringes
    • Inhalers
    • Patch Pumps
    • Others
  • Europe Drug Delivery Devices Market, By Patient Care Setting:
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Surgery Centers/Clinics
    • Home Care Settings
    • Others
  • Europe Drug Delivery Devices Market, By Application:
    • Cancer
    • Infectious Diseases
    • Respiratory Diseases
    • Diabetes
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Central Nervous System Disorders
    • Others
  • Europe Drug Delivery Devices Market, By Country:
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Switzerland
    • Netherlands
    • Turkey
    • Sweden
    • Belgium

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe drug delivery devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Europe drug delivery devices market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Europe Drug Delivery Devices Market

4.    Executive Summary

5.    Voice of Customer

6.    Europe Drug Delivery Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery)

6.2.2.     By Device (Syringes, Inhalers, Patch Pumps, And Others)

6.2.3.     By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others)

6.2.4.     By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others)

6.2.5.     By Country

6.2.6.     By Company

6.3.  Market Attractiveness Index

6.4.  Europe: Country Analysis

6.4.1.     France Drug Delivery Devices Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Route of Administration

6.4.1.2.2.             By Device

6.4.1.2.3.             By Patient Care Setting

6.4.1.2.4.             By Application

6.4.2.     Germany Drug Delivery Devices Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Route of Administration

6.4.2.2.2.             By Device

6.4.2.2.3.             By Patient Care Setting

6.4.2.2.4.             By Application

6.4.3.     United Kingdom Drug Delivery Devices Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Route of Administration

6.4.3.2.2.             By Device

6.4.3.2.3.             By Patient Care Setting

6.4.3.2.4.             By Application

6.4.4.     Italy Drug Delivery Devices Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Route of Administration

6.4.4.2.2.             By Device

6.4.4.2.3.             By Patient Care Setting

6.4.4.2.4.             By Application

6.4.5.     Spain Drug Delivery Devices Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Route of Administration

6.4.5.2.2.             By Device

6.4.5.2.3.             By Patient Care Setting

6.4.5.2.4.             By Application

6.4.6.     Switzerland Drug Delivery Devices Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Route of Administration

6.4.6.2.2.             By Device

6.4.6.2.3.             By Patient Care Setting

6.4.6.2.4.             By Application

6.4.7.     Netherlands Drug Delivery Devices Market Outlook

6.4.7.1.         Market Size & Forecast

6.4.7.1.1.             By Value  

6.4.7.2.         Market Share & Forecast

6.4.7.2.1.             By Route of Administration

6.4.7.2.2.             By Device

6.4.7.2.3.             By Patient Care Setting

6.4.7.2.4.             By Application

6.4.8.     Russia Drug Delivery Devices Market Outlook

6.4.8.1.         Market Size & Forecast

6.4.8.1.1.             By Value

6.4.8.2.         Market Share & Forecast

6.4.8.2.1.             By Route of Administration

6.4.8.2.2.             By Device

6.4.8.2.3.             By Patient Care Setting

6.4.8.2.4.             By Application

6.4.9.     Sweden Drug Delivery Devices Market Outlook

6.4.9.1.         Market Size & Forecast

6.4.9.1.1.             By Value

6.4.9.2.         Market Share & Forecast

6.4.9.2.1.             By Route of Administration

6.4.9.2.2.             By Device

6.4.9.2.3.             By Patient Care Setting

6.4.9.2.4.             By Application

6.4.10.  Belgium Drug Delivery Devices Market Outlook

6.4.10.1.      Market Size & Forecast

6.4.10.1.1.           By Value

6.4.10.2.      Market Share & Forecast

6.4.10.2.1.           By Route of Administration

6.4.10.2.2.           By Device

6.4.10.2.3.           By Patient Care Setting

6.4.10.2.4.           By Application

7.    Market Dynamics

7.1.  Drivers

7.2.  Challenges

8.    Market Trends & Developments

9.    Competitive Landscape

9.1.  F. Hoffmann-La Roche Ltd

9.2.  Antares Pharma

9.3.  Novartis AG

9.4.  3M Company

9.5.  Sulzer Ltd

9.6.  Gerresheimer AG

9.7.  Sanofi S.A.

9.8.  Johnson & Johnson Services, Inc.

9.9.  Bayer AG

9.10.              GlaxoSmithKline plc

9.11.              Novosanis

9.12.              MEDMIX SYSTEMS AG

9.13.              Merck & Co., Inc.

9.14.              Pfizer Inc.

9.15.              Insulet Corporation

9.16.              OraSure Technologies, Inc.

9.17.              West Pharmaceutical Services, Inc.

9.18.              SMC Ltd.

9.19.              ViVO Smart Medical Devices Ltd.

9.20.              Cipla Inc.

10.  Strategic Recommendations

11. About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com